{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:15:29Z","timestamp":1715991329535},"reference-count":50,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Associazione Italiana Ricerca sul Cancro (AIRC)."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.2217\/imt-2017-0139","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T08:08:51Z","timestamp":1531728531000},"page":"753-767","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Survivin-Peptide Vaccination Elicits Immune Response after Allogeneic Nonmyeloablative Transplantation: A Safe Strategy to Enhance the Graft Versus Tumor Effect"],"prefix":"10.1080","volume":"10","author":[{"given":"Paola","family":"Circosta","sequence":"first","affiliation":[{"name":"Molecular Biotechnology Center, University of Torino, 10126Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Vitaggio","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Rita","family":"Elia","sequence":"additional","affiliation":[{"name":"Molecular Biotechnology Center, University of Torino, 10126Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Todorovic","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Oncology-Experimental Cell Therapy, Candiolo Cancer Institute-FPO-IRCCS, 10060 Candiolo, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Sangiolo","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Turin, Italy"},{"name":"Laboratory of Medical Oncology-Experimental Cell Therapy, Candiolo Cancer Institute-FPO-IRCCS, 10060 Candiolo, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Carnevale-Schianca","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, University of Torino Medical School, 10060 Candiolo, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Vallario","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Piemonte Orientale Amedeo Avogadro,\r28100\rNovara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Geuna","sequence":"additional","affiliation":[{"name":"Laboratory of Immunopathology Mauriziano Hospital &amp; University of Torino, 10128\rTurin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aglietta","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, University of Torino Medical School, 10060 Candiolo, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cignetti","sequence":"additional","affiliation":[{"name":"Molecular Biotechnology Center, University of Torino, 10126Turin, Italy"},{"name":"University Division of Hematology &amp; Cell Therapy, Mauriziano Umberto I Hospital &amp; University of Torino,10128 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1558"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.292"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2010.83"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-514786"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.225"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-3945"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.05.011"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1708"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.4.2368"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24014"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00036"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.031674"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.014704"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-202598"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.16"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2013.67"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401894"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.06.014"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.29"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.226"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0405884101"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2014.953925"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0326-1"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1722"},{"issue":"15","key":"e_1_3_3_27_1","first-page":"4507","article-title":"The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients","volume":"63","author":"Casati C","year":"2003","unstructured":"Casati C , DalerbaP , RivoltiniLet al. The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients . Cancer Res.63 ( 15 ), 4507 \u2013 4515 ( 2003 ).","journal-title":"Cancer Res."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2554"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12456"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1890-x"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1026529"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1516-5"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12046"},{"key":"e_1_3_3_34_1","first-page":"262967","article-title":"Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer\u2013results from Phase I clinical trials","author":"Tanaka T","year":"2013","unstructured":"Tanaka T , KitamuraH , InoueRet al. Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer\u2013results from Phase I clinical trials . Clin. Dev. Immunol.2013 , 262967 ( 2013 ).","journal-title":"Clin. Dev. Immunol."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1266-9"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.08.007"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1516"},{"issue":"3","key":"e_1_3_3_38_1","first-page":"869","article-title":"Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients","volume":"61","author":"Andersen MH","year":"2001","unstructured":"Andersen MH , PedersenLO , BeckerJC , StratenPT . Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients . Cancer Res.61 ( 3 ), 869 \u2013 872 ( 2001 ).","journal-title":"Cancer Res."},{"issue":"16","key":"e_1_3_3_39_1","first-page":"5964","article-title":"Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients","volume":"61","author":"Andersen MH","year":"2001","unstructured":"Andersen MH , PedersenLO , CapellerB , BrockerEB , BeckerJC , thor StratenP . Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients . Cancer Res.61 ( 16 ), 5964 \u2013 5968 ( 2001 ).","journal-title":"Cancer Res."},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.227"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002514"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.20594"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2009.03.003"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.03.001"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.03.505"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.11.6253"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43437"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.215"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75876"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.11.004"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1212"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0871-8"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2017-0139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:07:42Z","timestamp":1715962062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2017-0139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.2217\/imt-2017-0139"],"URL":"https:\/\/doi.org\/10.2217\/imt-2017-0139","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}